Make medical projects work & green field investments

Make medical projects work

  • Recognize the rules of the Marketplace and apply the change in your favor
  • Identify relevant trends and assess threats & opportunities
  • We are tuning in quickly on the critical issues
  • Need of early understanding of issues to ensure smooth implementation of findings
  • Projects on Privatization of State owned Healthcare Assets
  • Industrial Strategy and Diversification
  • Focused M&A

Market access

About the venture

Corporate Dynamics founded a company servicing the pharmaceutical and biotech industries.The company registers, promotes and distributes innovative pharmaceutical products in Romania for large Pharma and Biotech Companies. Since its creation, Geneva Romfarm International has worked with such companies as Abbott Laboratories, Merck Serono, Jansen, Actelion, Rhodia, Piramal.Geneva Romfarm International has been successful in creating and enlarging the market for the innovative treatments and, by doing so, bettering the lives of thousands of patients.

Business System

Market Intelligence
GRFI Capabilities and Strengths
  • Proprietary data
  • Framework: Healthcare Authorities
  • National Healthcare Programs
  • Thought leaders
  • Competitive analysis / strategy
  • Market Research
A New Product Introduction Strategy
GRFI Capabilities and Strengths
  • Dynamic strategy design
  • Communication and promotional materials
  • Gradual awareness building
  • Legal requirements
  • Partnership and participation with thought leaders
Regulatory and Pricing
GRFI Capabilities and Strengths
  • Experience in file submission and updating
  • Familiarity with regulatory / pricing practice
  • Adaptation of EMEA, FDA documentation
  • Good working relation with regulatory bodies
  • Cost / benefit studies, co-operation with CROs
Promotion and Branding
GRFI Capabilities and Strengths
  • Positioned in prescribers mind
  • Proven practice in branding
  • Event management
  • All medical representatives are MDs
  • Full territorial coverage
  • Visibility at patient level
  • Work with patient associations
Logistics and Distribution
GRFI Capabilities and Strengths
  • Product import
  • Warehousing inventory management
  • Consignment stock management
  • Patient support

Therapeutic Areas

For over twenty years Geneva Romfarm International has been actively, importing, registering, promoting and distributing in Romania, some of the World’s most innovative treatments. With a field of expertise ranging from general medicine, to the very specialized tasks of introducing revolutionary drugs for rare diseases, the company is held in the highest regards by the country’s leading physicians, healthcare authorities and patient associations. We believe that by fostering and maintaining strong ties with patient and professional associations, we achieve an unsurpassed level of feedback from the market that actively plays a role in the way the company acts and reacts to environmental changes. We also believe in our ethical and civic responsibilities to educate and collaborate with all of our stakeholders.

Geneva Romfarm International created and developed markets for orphan drugs, therapies dedicated to rare diseases as Pulmonary Arterial Hypertension (PAH) and Multiple Sclerosis (MS).

“Orphan drugs” are pharmaceutical products intended for prevention or treatment of life-threatening or debilitating rare diseases. They are “orphans” because there is little interest under normal market conditions in developing and marketing drugs intended for only a small number of patients suffering from very rare conditions.

CARDIOLOGY / PNEUMOLOGY / RARE DISEASES

  • Pulmonary Arterial Hypertension (PAH)
  • TRACLEER
  • Created and developed local market
  • Established awareness campaigns for key stakeholders
  • Formed screening programs to discover misdiagnosed and neglected patients
  • Key contributor to the creation of a national PAH reimbursement program
  • OPSUMIT
  • Included, since November 2015, in the national PAH reimbursement program

RHEUMATOLOGY / RARE DISEASES

  • Digital ulcers from scleroderma
  • TRACLEER
  • Created and developed local market
  • Established awareness campaigns for key stakeholders
  • Formed screening programs to discover misdiagnosed and neglected patients
  • Key contributor to the creation of a national digital ulcers reimbursement program

NEURODEGENERATIVE DISEASES

  • Multiple Sclerosis (MS)
  • REBIF
  • Achieved substantial market share within the 1st year of promotion as one of the best in market therapy
  • Forged strong bonds with the MS Patient Association.
  • Key contributor to the creation of a national MS reimbursement program

INFERTILITY

  • In Vitro Fertilization (IVF)
  • GONAL-F, LUVERIS, CETROTIDE
  • Changed prescribers behavior by introducing the first biotech for IVF on the market
  • Leading Market Position
  • Key contributor to the creation of a national IVF reimbursement program

INTENSIVE CARE

  • SEVORANE, FORANE (Inhalation Anesthesia)
  • PROPOFOL, BUPIVACAINE (Local Anesthesia)
  • Market Leader; Introduced a new concept and new guidelines to use vaporized anesthesiology products. Professional collaboration with the society of anesthesiologists (trainings, workshops)
  • Equipment: Infusion Pumps, Devices, Monitoring Devices

INFECTIOUS DISEASES

  • KLACID
  • Introduced New Generation Macrolides into the market, a powerful tool for physicians activating in the field of IINTERNAL MEDICINE, GASTROENTELOLOGY, PNEUMOLOGY, OTORHINOLARYNGOLOGY, GENERAL MEDICINE
  • Major contributor to changing the approach to treating peptic ulcers

PEDIATRICS / NEONATOLOGY

  • SIMILAC
  • Introduced Best and First in Market in products for the nutrition of healthy and sick children
  • SURVANTA
  • Introduced Surfactant for pediatric intensive care
  • BERACTANT, PHENEX, FERROGRADUMET, VIDAYLIN
  • Introduced new products for children

ENTERAL NUTRITION AND PALLIATIVE CARE ONCOLOGY

  • PULMOCARE
  • Successfully introduced, a high-calorie, low-carbohydrate formula designed to help reduce carbon dioxide production, which is helpful for patients with chronic obstructive pulmonary disease (COPD), cystic fibrosis or respiratory failure

HIV-AIDS

  • NORVIR, KALETRA
  • Introduced revolutionary treatments with protease inhibitors in Romania and created strong ties to patient associations

PSYCHIATRY

  • RISPERDAL, HALDOL
  • Active and important presence on antipsychotic market

DERMATOLOGY

  • NIZORAL, RAPTIVA, SELSUN

UROLOGY

  • HYTRIN
  • Very active and succesfull presence in the urology field

Green field investments

Medical Centers
Pharmaceutical
Operations
Facility
Development

Joint operations with pharmaceutical companies: Abbott, Merck-Serono, Actelion